Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1996-07-12
1998-12-15
Criares, Theodore J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514415, A61K 3121, A61K 31255
Patent
active
058497820
ABSTRACT:
Methods for inhibiting a nitric oxide-mediated pathological condition and a neurodegenerative disease such as Parkinson's disease, Huntington's disease, Alzheimers's disease, and amyotrophic lateral sclerosis in a human patient, comprising administering an effective amount of a nitroindazole capable of inhibiting a neuronal nitric oxide synthase.
REFERENCES:
patent: 5266594 (1993-11-01), Dawson et al.
Moore, P.K. et al., British Journal of Pharmacology, vol. 108, No. 2, issued Feb. 1993, pp. 296-297.
Babbage et al; "Indazoles a novel group of Nitric Oxide Synthase Inhibitors", 1993 British J. of Pharm. vol. 109 Sup. 142p Merck Manual of Diagnosis & Therapy; Sixteenth Edition, Division of Merck & Co Inc pp. 1512-1513 (1992).
Criares Theodore J.
The General Hospital Corporation
LandOfFree
Methods of inhibiting neurodegenerative diseases does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods of inhibiting neurodegenerative diseases, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods of inhibiting neurodegenerative diseases will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1458444